ScreenerHero

VANI Vivani Medical, Inc.

NAS · US · Healthcare · Biotechnology · vivani.com
1.270USD+2.42%Mkt Cap: 114.56M $P/E: —

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap114.56M USD
Enterprise Value109.81M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.61M USD
Revenue/Share—
Last Price1.270 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees42
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.54
PEG—
EV/EBITDA-4.09
EV/Revenue—
P/S—
P/B5.85
EPS (TTM)-0.36
EPS (Forward)-0.35
52W Range
0.923035% of range1.920
52W High1.920 USD
52W Low0.9230 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-169.16%
ROA-67.55%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.32M USD
CapEx (TTM)1.17M USD
FCF Margin—
FCF Yield-14.69%
Net Debt-2.04M USD
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity1.20
Current Ratio3.25
Quick Ratio3.09
Book Value/Sh0.21 USD
Cash/Share0.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateJan 6, 2020
Splits
Last Split1:3
Split DateAug 19, 2022
Analyst Consensus
Rating—
Target (Mean)3.833 USD
Upside (mean)+201.8%
Target Range3.500 USD – 4.000 USD
3.500+201.8% to mean4.000
# Analysts3
Ownership
Shares Out.90.20M
Float38.94M
Insiders55.39%
Institutions5.89%
Short Interest
Short Ratio2.8d
Short % Float1.46%
Short % Out.0.77%
Shares Short694.27K
Short (prev mo.)530.09K
Technical
SMA 501.324 (-4.1%)
SMA 2001.270 (-0.0%)
Beta3.30
S&P 52W Chg16.45%
Avg Vol (30d)219.04K
Avg Vol (10d)108.86K
Technical Indicators
RSI (14)49.2
MACD-0.0268
MACD Signal-0.0300
MACD Hist.+0.0032
BB Upper1.391 USD
BB Middle1.262 USD
BB Lower1.132 USD
BB Width20.47%
ATR (14)0.0585 USD
Vol Ratio (20d)1.25x